See up to 3 months of ARDX. The 7-day demo opens the 1M and 3M ranges and puts ARDX on your watchlist.
Start 7-day demoLatest ARDX insider trades
About ARDELYX, INC. (ARDX)
ARDELYX, INC. files with the SEC under CIK 0001437402 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ARDX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 22 | 167,727 | $697K |
| Option exercise | 2 | 41,668 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ARDX insider transactions (Form 4)
7784 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Susan Hohenleitner - Officer | Open-market sale | Common Stock | 1,558 | $3.86 | $6K | |
| Joseph James Reilly - Officer | Open-market sale | Common Stock | 2,872 | $3.86 | $11K | |
| Joseph James Reilly - Officer | Open-market sale | Common Stock | 1,110 | $3.86 | $4K | |
| John E. Bishop - Officer | Open-market sale | Common Stock | 17,281 | $3.86 | $67K | |
| John E. Bishop - Officer | Open-market sale | Common Stock | 2,469 | $3.86 | $10K | |
| James Parker Brady - Officer | Open-market sale | Common Stock | 1,976 | $3.86 | $8K | |
| James Parker Brady - Officer | Open-market sale | Common Stock | 13,160 | $3.86 | $51K | |
 Eric Duane Foster - Officer | Open-market sale | Common Stock | 2,598 | $3.86 | $10K | |
| Eric Duane Foster - Officer | Open-market sale | Common Stock | 3,389 | $3.86 | $13K | |
| Eric Duane Foster - Officer | Open-market sale | Common Stock | 2,575 | $3.86 | $10K | |
| Mike Kelliher - Officer | Open-market sale | Common Stock | 3,104 | $3.86 | $12K | |
| Mike Kelliher - Officer | Open-market sale | Common Stock | 2,652 | $3.86 | $10K | |
| Mike Kelliher - Officer | Open-market sale | Common Stock | 2,002 | $3.86 | $8K | |
 Laura A. Williams - Officer | Open-market sale | Common Stock | 3,486 | $3.86 | $13K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 3,089 | $3.86 | $12K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 2,430 | $3.86 | $9K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 1,734 | $3.86 | $7K | |
 Michael Raab - Officer | Open-market sale | Common Stock | 15,009 | $3.86 | $58K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 15,976 | $3.86 | $62K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 8,411 | $3.86 | $32K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 19,178 | $3.86 | $74K | |
| Michael Raab - Officer | Option exercise | Common Stock | 20,834 | $0.99 | $21K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 41,668 | $5.06 footnote F2 | $211K | |
| Michael Raab - Officer | Option exercise | Stock Option (Right to Buy) | 20,834 | $0.00 | - | |
| ||||||
| Laura A. Williams - Officer | Option exercise | Common Stock | 31,000 | $0.99 | $31K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 81,898 | $5.99 footnote F2 | $490K | |
| Laura A. Williams - Officer | Option exercise | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| ||||||
| Merdad Parsey - Director | Grant or award | Common Stock | 26,455 footnote F1 | $0.00 | - | |
| Merdad Parsey - Director | Grant or award | Stock Option (Right to Buy) | 39,715 footnote F2 | $0.00 | - | |
| ||||||
| Richard J. Rodgers - Director | Grant or award | Stock Option (Right to Buy) | 39,715 footnote F2 | $0.00 | - | |
| Richard J. Rodgers - Director | Grant or award | Common Stock | 26,455 footnote F1 | $0.00 | - | |
| ||||||
 David M. Mott - Director | Grant or award | Common Stock | 26,455 footnote F3 | $0.00 | - | |
| David M. Mott - Director | Grant or award | Stock Option (Right to Buy) | 39,715 footnote F4 | $0.00 | - | |
| David M. Mott - Director | Grant or award | Common Stock | 20,282 footnote F1 | $0.00 | - | |
| ||||||
 Onaiza Cadoret-Manier - Director | Grant or award | Stock Option (Right to Buy) | 39,715 footnote F2 | $0.00 | - | |
| Onaiza Cadoret-Manier - Director | Grant or award | Common Stock | 26,455 footnote F1 | $0.00 | - | |
| ||||||
 Muna Bhanji - Director | Grant or award | Common Stock | 26,455 footnote F1 | $0.00 | - | |
| Muna Bhanji - Director | Grant or award | Stock Option (Right to Buy) | 39,715 footnote F2 | $0.00 | - | |
| ||||||
| William C. Bertrand Jr. - Director | Grant or award | Common Stock | 26,455 footnote F2 | $0.00 | - | |
| William C. Bertrand Jr. - Director | Grant or award | Stock Option (Right to Buy) | 39,715 footnote F3 | $0.00 | - | |
| William C. Bertrand Jr. - Director | Grant or award | Common Stock | 12,345 footnote F1 | $0.00 | - | |
| ||||||
| Robert B. Bazemore - Director | Grant or award | Stock Option (Right to Buy) | 39,715 footnote F2 | $0.00 | - | |
| Robert B. Bazemore - Director | Grant or award | Common Stock | 26,455 footnote F1 | $0.00 | - | |
| ||||||
| Michael Raab - Officer | Option exercise | Common Stock | 20,833 | $0.99 | $21K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 41,666 | $5.67 footnote F2 | $236K | |
| Michael Raab - Officer | Option exercise | Stock Option (Right to Buy) | 20,833 | $0.00 | - | |
| ||||||
| Joseph James Reilly - Officer | Open-market sale | Common Stock | 2,683 | $6.27 | $17K | |
| Joseph James Reilly - Officer | Open-market sale | Common Stock | 1,036 | $6.27 | $6K | |
| Susan Hohenleitner - Officer | Open-market sale | Common Stock | 1,455 | $6.27 | $9K | |
| John E. Bishop - Officer | Open-market sale | Common Stock | 2,306 | $6.27 | $14K | |
| James Parker Brady - Officer | Open-market sale | Common Stock | 1,846 | $6.27 | $12K | |
| Eric Duane Foster - Officer | Open-market sale | Common Stock | 3,166 | $6.27 | $20K | |
| Eric Duane Foster - Officer | Open-market sale | Common Stock | 2,427 | $6.27 | $15K | |
| Eric Duane Foster - Officer | Open-market sale | Common Stock | 2,405 | $6.27 | $15K | |
| Mike Kelliher - Officer | Open-market sale | Common Stock | 2,900 | $6.27 | $18K | |
| Mike Kelliher - Officer | Open-market sale | Common Stock | 1,870 | $6.27 | $12K | |
| Mike Kelliher - Officer | Open-market sale | Common Stock | 2,478 | $6.27 | $16K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 1,503 | $6.27 | $9K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 2,157 | $6.27 | $14K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 1,911 | $6.27 | $12K | |
| Laura A. Williams - Officer | Open-market sale | Common Stock | 1,418 | $6.27 | $9K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 14,933 | $6.27 | $94K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 7,861 | $6.27 | $49K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 17,926 | $6.27 | $112K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 14,028 | $6.27 | $88K | |
| Michael Raab - Officer | Option exercise | Common Stock | 20,833 | $0.99 | $21K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 41,666 | $6.28 footnote F2 | $262K | |
| Michael Raab - Officer | Option exercise | Stock Option (Right to Buy) | 20,833 | $0.00 | - | |
| ||||||
| Michael Raab - Officer | Option exercise | Common Stock | 20,834 | $0.99 | $21K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 41,668 | $6.29 footnote F2 | $262K | |
| Michael Raab - Officer | Option exercise | Stock Option (Right to Buy) | 20,834 | $0.00 | - | |
| ||||||
| Michael Raab - Officer | Option exercise | Common Stock | 20,833 | $0.99 | $21K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 41,666 | $5.84 footnote F2 | $243K | |
| Michael Raab - Officer | Option exercise | Stock Option (Right to Buy) | 20,833 | $0.00 | - | |
| ||||||
| Michael Raab - Officer | Option exercise | Common Stock | 20,833 | $0.99 | $21K | |
| Michael Raab - Officer | Open-market sale | Common Stock | 41,666 | $6.26 footnote F2 | $261K | |
| Michael Raab - Officer | Option exercise | Stock Option (Right to Buy) | 20,833 | $0.00 | - | |
| ||||||
Item 8.01
Item 2.02, 7.01, 9.01
Item 2.03, 9.01
Item 5.02, 5.07
Recent ARDX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Williams Laura A | Officer | 10,500 | $42K | View on EDGAR | |
| Bishop John E | Officer | 25,500 | $103K |
ARDX insider trading FAQ
What is the latest insider trade for ARDX?
ARDELYX, INC. (ARDX) had 9 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for ARDX runs to 84 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ARDX stock?
No insider purchases of ARDX were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling ARDX stock?
22 insider sales of ARDX were filed in the last 90 days, totaling $697K.
Where can I see ARDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ARDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Susan Hohenleitner view on EDGAR
- - Joseph James Reilly view on EDGAR
- - John E. Bishop view on EDGAR
- - James Parker Brady view on EDGAR
- - Eric Duane Foster view on EDGAR
- - Mike Kelliher view on EDGAR
- - Laura A. Williams view on EDGAR
- - Michael Raab view on EDGAR
- - Michael Raab view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ARDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ARDX with a 7-day demo
- ARDX on your watchlist
- Every ARDX Form 4 filing on record
- Up to 3 months of ARDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
